Lucira Health to Participate in Bank of America 2022 Healthcare Conference
May 04 2022 - 7:00AM
Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical
technology company focused on the development and commercialization
of transformative and innovative infectious disease test kits,
today announced that the company will participate in the Bank of
America 2022 Healthcare Conference on May 11th, 2022, at 11:00pm
ET.
Lucira’s management is scheduled to present at the Bank of
America 2022 Healthcare Conference on May 11th, 2022, at 11:00pm
ET. A live and archived webcast of the event can be accessed
through the Events and Presentations page of the Lucira
website.
About Lucira HealthLucira is a medical
technology company focused on the development and commercialization
of transformative and innovative infectious disease tests. Lucira's
testing platform produces lab quality molecular testing in a
single-use, consumer-friendly, palm-size test kit powered by two AA
batteries. Lucira designed its test kits to provide accurate,
reliable, and on-the-spot molecular test results anywhere and at
any time.
Beyond its COVID-19 tests, Lucira is working on new diagnostic
tests including a single test for COVID-19 & Flu as well as
other infectious diseases. For more information, visit
www.lucirahealth.com.
Investor ContactGreg
ChodaczekInvestorrelations@lucirahealth.com332-895-3230
Lucira Health (NASDAQ:LHDX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Lucira Health (NASDAQ:LHDX)
Historical Stock Chart
From Jul 2023 to Jul 2024